Related references
Note: Only part of the references are listed.Conditional ablation of Stat3 or Socs3 discloses a dual role for reactive astrocytes after spinal cord injury
Seiji Okada et al.
NATURE MEDICINE (2006)
Basso mouse scale for locomotion detects differences in recovery after spinal cord in ury in five common mouse strains
DM Basso et al.
JOURNAL OF NEUROTRAUMA (2006)
Microarray analysis of gene expression patterns in adult spinal motoneurons after different types of axonal injuries
Y Yang et al.
BRAIN RESEARCH (2006)
Growth factor and cytokine regulation of chondroitin sulfate proteoglycans by astrocytes
GM Smith et al.
GLIA (2005)
Coordinating ERK/MAPK signalling through scaffolds and inhibitors
W Kolch
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
Intrapulmonary IFN-β gene therapy using an adenoviral vector is highly effective in a murine orthotopic model of bronchogenic adenocarcinoma of the lung
MJ Wilderman et al.
CANCER RESEARCH (2005)
Mechanisms of type-I- and type-II-interferon-mediated signalling
LC Platanias
NATURE REVIEWS IMMUNOLOGY (2005)
Reactive astrocytes protect tissue and preserve function after spinal cord injury
JR Faulkner et al.
JOURNAL OF NEUROSCIENCE (2004)
IFNα induces Fas expression and apoptosis in hedgehog pathway activated BCC cells through inhibiting Ras-Erk signaling
CX Li et al.
ONCOGENE (2004)
Regeneration beyond the glial scar
J Silver et al.
NATURE REVIEWS NEUROSCIENCE (2004)
Spatial and temporal gene expression profiling of the contused rat spinal cord
JB Aimone et al.
EXPERIMENTAL NEUROLOGY (2004)
ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions
PP Roux et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2004)
Human gene therapy for malignant gliomas (glioblastoma multiforme and anaplastic astrocytoma) by in vivo transduction with human interferon beta gene using cationic liposomes
J Yoshida et al.
HUMAN GENE THERAPY (2004)
Ascending sensory, but not other long-tract axons, regenerate into the connective tissue matrix that forms at the site of a spinal cord injury in mice
DM Inman et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2003)
Mechanisms of regulating the Raf kinase family
H Chong et al.
CELLULAR SIGNALLING (2003)
Clinical gene therapy for brain tumors. Liposomal delivery of anticancer molecule to glioma
J Yoshida et al.
JOURNAL OF NEURO-ONCOLOGY (2003)
Direct evidence that IFN-β functions as a tumor-suppressor protein
C Kaynor et al.
JOURNAL OF INTERFERON AND CYTOKINE RESEARCH (2002)
MEK and ERK inhibitors enhance the antiproliferative effect of interferon-α2b
F Romerio et al.
FASEB JOURNAL (2002)
GeneChip® analysis after acute spinal cord injury in rat
GQ Song et al.
JOURNAL OF NEUROCHEMISTRY (2001)
Interferon-α2b reduces phosphorylation and activity of MEK and ERK through a Ras/Raf-independent mechanism
F. Romerio et al.
BRITISH JOURNAL OF CANCER (2000)
Second-generation interferons for cancer: clinical targets
EC Borden et al.
SEMINARS IN CANCER BIOLOGY (2000)
IFN-β gene therapy induces systemic antitumor immunity against malignant glioma
A Natsume et al.
JOURNAL OF NEURO-ONCOLOGY (2000)
IFN-alpha 2b reduces IL-2 production and IL-2 receptor function in primary CD4(+) T cells
D Zella et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
